维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="Knowlden"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	A possible divergentrole for the oestrogen receptor alpha and beta subtypes in clinical breastcancer显示文摘	KNOWLDEN J M GEE J M ROBERTSON J F	2000	Int J Cancer2000，89，：	1
2	Identification and independent regulation of human mesangial cell metalloproteinases 显示文摘	Martin J Knowlden MD Davies M	1994	Kidney Int1994，46，：	1
3	Insulinlike growth factor-Ⅰ receptor signaling in tamoxifenresistant breast cancer:a supporting role to the epidermal growth factor receptor显示文摘	Knowlden JM Hutcheson IR Barrow D		0，，11：	1
4	Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling:implication for Gefitinib (' Iressa') response and resistance显示文摘	Knowlden JM Jones HE Barrow D		0，，01：	1
5	Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination显示文摘	Nicholson R I Hutcheson I R Knowlden J M	2004	Clin Cancer Res2004，10，12：	1
6	Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells显示文摘	Knowlden J M Hutcheson I R Jones H E	2003	Endocrinology2003，144，3：	1
7	Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro显示文摘	Martin J Steadman R Knowlden J	1998	J Am Soc Nephrol1998，9，8：	1
8	BRCA1 expression levels predict distant metastasis of sporadic breast cancers显示文摘	Seery LT Knowlden JM Gee JM	1999	Int J Cancer1999，84，5：	1
9	Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates ta- moxifen-resistant growth显示文摘	Britton DJ Hutcheson IR Knowlden JM	2006	Breast Cancer Res Treat2006，96，2：	1
10	Insulin-like growth factor-I receptor signaling in tamoxifenresistant breast cancer:a supporting role to the epidermal growth factor receptor显示文摘	KNOWLDEN J M HUTCHESON I R BARROW D	2005	Endocrinology2005，146，11：	1
11	c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer显示文摘	Knowlden JM Gee JM Seery LT	1998	Oncogene1998，17，15：	1
12	Nonendocrine pathways and resistance:obser- rations with antiestrongens and transduction inbihitors in combination显示文摘	Nicholson RI HuTCheson IR Knowlden JM	2004	Clin Cancer Res2004，10，：	1
13	Health belief structural equation model predicting sleep behavior of employed college students 显示文摘	Knowlden AP Sharma M	2014	Fam Community Health2014，37，4：	1
14	A possible divergent role for the oestrogen receptor α and β subtypes in clinical breast cancer显示文摘	Gee JM Robertson JF	2000	Int J Cancer2000，89，2：	1
15	Differential expression ofoestrogen regulated genes in breast cancer 显示文摘	Manning DL McClelland RA Knowlden JM	1995	Acta Oncol1995，34，：	1
16	Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resietant MCF-7 Cells显示文摘	Knowlden J M Hutcheson I R Jones H E	2003	Endocrinol2003，144，3：	1
17	Identification and independent regulation of human mesangial cell metalloproteinases显示文摘	Martin J Knowlden J Davies M	1994	Kidney Int1994，46，：	1
18	Identification and independent regulation of hu-man mesangial cell metalloproteinases显示文摘	John Martin Janice Knowlden Malcolm Davies	1994	Kidney Int1994，46，：	1
19	Insulin-like growth factor-1 receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor 显示文摘	Knowlden J M Hutcheson I R Barrow D	2005	Endocrinology2005，146，11：	1
20	Bidirectional cross talk between ERalpha and EGFR sagrtalling patharays regulates tamoxifen-resistant growth显示文摘	Britton DJ Hutcheson IR Knowlden JM	2006	Breast Cancer Res Treat2006，96，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示